Literature DB >> 17223965

T and B lymphocyte subpopulations and activation/differentiation markers in patients with selective IgA deficiency.

J Litzman1, M Vlková, Z Pikulová, D Stikarovská, J Lokaj.   

Abstract

Selective deficiency of immunoglobulin A (IgAD) and common variable immunodeficiency (CVID) are genetically closely related diseases, both of unknown pathogenesis. A plethora of abnormalities in lymphocyte subpopulations and expression of activation markers were repeatedly documented in CVID patients, while almost no data are available about lymphocyte subpopulations in IgAD patients. We determined basic lymphocyte subpopulations and those subpopulations that were reported to be abnormal in CVID patients (CD25, human leucocyte antigen (HLA)-DR CD45RA, CD45RO, CD27, CD28 and CD29 on both CD4(+) and CD8(+) cells, CD57 and CD38 on CD8(+) cells, CD21, CD27, IgM, IgD on B lymphocytes) in 85 patients with IgAD, 47 patients with CVID and in 65 healthy controls. Statistical analysis was performed by the Mann-Whitney U-test; significant P-values were determined by means of Bonferoni's correction. Our results showed an increase in the relative number of CD8(+) cells and a decrease in the absolute number of CD4(+) cells compared to healthy people, but similar abnormalities in CVID patients were much more expressed. IgAD patients had significantly decreased expression of HLA-DR and increased expression of CD25 on CD4(+) lymphocytes, also CD29 expression was decreased on CD8(+) cells, while other activation/differentiation markers on T cells (including the expression of CD45RA and CD45RO antigens) were not changed. There were no statistically significant abnormalities in B lymphocyte developmental stages in IgAD patients compared to healthy controls. Our observation showed that the majority of T and B lymphocyte subpopulation abnormalities described previously in CVID are not present in IgAD patients.

Entities:  

Mesh:

Year:  2007        PMID: 17223965      PMCID: PMC1810464          DOI: 10.1111/j.1365-2249.2006.03274.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  31 in total

1.  Absence of memory B cells in patients with common variable immunodeficiency.

Authors:  Kazunaga Agematsu; Takeshi Futatani; Sho Hokibara; Norimoto Kobayashi; Masaya Takamoto; Satoshi Tsukada; Harumi Suzuki; Shigeo Koyasu; Toshio Miyawaki; Kazuo Sugane; Atsushi Komiyama; Hans D Ochs
Journal:  Clin Immunol       Date:  2002-04       Impact factor: 3.969

2.  Impaired secretion of IL-10 by T cells from patients with common variable immunodeficiency--involvement of protein kinase A type I.

Authors:  Are Martin Holm; Pål Aukrust; Einar Martin Aandahl; Fredrik Müller; Kjetil Taskén; Stig S Frøland
Journal:  J Immunol       Date:  2003-06-01       Impact factor: 5.422

3.  Age dependency and mutual relations in T and B lymphocyte abnormalities in common variable immunodeficiency patients.

Authors:  M Vlková; V Thon; M Sárfyová; L Bláha; A Svobodník; J Lokaj; J Litzman
Journal:  Clin Exp Immunol       Date:  2006-02       Impact factor: 4.330

4.  Severe deficiency of switched memory B cells (CD27(+)IgM(-)IgD(-)) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogeneous disease.

Authors:  Klaus Warnatz; Axel Denz; Ruth Dräger; Moritz Braun; Christoph Groth; Guido Wolff-Vorbeck; Hermann Eibel; Michael Schlesier; Hans Hartmut Peter
Journal:  Blood       Date:  2002-03-01       Impact factor: 22.113

5.  Study of the B cell memory compartment in common variable immunodeficiency.

Authors:  J C Brouet; A Chedeville; J P Fermand; B Royer
Journal:  Eur J Immunol       Date:  2000-09       Impact factor: 5.532

6.  IgA deficiency in Czech healthy individuals and selected patient groups.

Authors:  J Litzman; I Sevcíková; D Stikarovská; Z Pikulová; A Pazdírková; J Lokaj
Journal:  Int Arch Allergy Immunol       Date:  2000-10       Impact factor: 2.749

7.  Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies).

Authors:  M E Conley; L D Notarangelo; A Etzioni
Journal:  Clin Immunol       Date:  1999-12       Impact factor: 3.969

8.  Common variable immunodeficiency patient classification based on impaired B cell memory differentiation correlates with clinical aspects.

Authors:  B Piqueras; C Lavenu-Bombled; L Galicier; F Bergeron-van der Cruyssen; L Mouthon; S Chevret; P Debré; C Schmitt; E Oksenhendler
Journal:  J Clin Immunol       Date:  2003-09       Impact factor: 8.317

Review 9.  Gender, age and seasonal effects on IgA deficiency: a study of 7293 Caucasians.

Authors:  D Weber-Mzell; P Kotanko; A C Hauer; U Goriup; J Haas; N Lanner; W Erwa; I A Ahmaida; S Haitchi-Petnehazy; M Stenzel; G Lanzer; J Deutsch
Journal:  Eur J Clin Invest       Date:  2004-03       Impact factor: 4.686

10.  Assessment of thymic output in common variable immunodeficiency patients by evaluation of T cell receptor excision circles.

Authors:  V Guazzi; F Aiuti; I Mezzaroma; F Mazzetta; G Andolfi; A Mortellaro; M Pierdominici; R Fantini; M Marziali; A Aiuti
Journal:  Clin Exp Immunol       Date:  2002-08       Impact factor: 4.330

View more
  8 in total

1.  Clinical and Laboratory Features of 184 Italian Pediatric Patients Affected with Selective IgA Deficiency (SIgAD): a Longitudinal Single-Center Study.

Authors:  Vassilios Lougaris; Annamaria Sorlini; Chiara Monfredini; Giulia Ingrasciotta; Andrea Caravaggio; Tiziana Lorenzini; Manuela Baronio; Marco Cattalini; Antonella Meini; Laura Ruggeri; Annamaria Salpietro; Alba Pilotta; Livia Grazzani; Elena Prandi; Barbara Felappi; Giulio Gualdi; Antonella Fabiano; Maurizio Fuoti; Alberto Ravelli; Vincenzo Villanacci; Annarosa Soresina; Raffaele Badolato; Alessandro Plebani
Journal:  J Clin Immunol       Date:  2019-05-25       Impact factor: 8.317

2.  B-lymphocyte subpopulations in patients with selective IgA deficiency.

Authors:  Jana Nechvatalova; Zdenka Pikulova; Dagmar Stikarovska; Sava Pesak; Marcela Vlkova; Jiri Litzman
Journal:  J Clin Immunol       Date:  2012-02-12       Impact factor: 8.317

3.  T cell phenotypes in patients with common variable immunodeficiency disorders: associations with clinical phenotypes in comparison with other groups with recurrent infections.

Authors:  E A L Bateman; L Ayers; R Sadler; M Lucas; C Roberts; A Woods; K Packwood; J Burden; D Harrison; N Kaenzig; M Lee; H M Chapel; B L Ferry
Journal:  Clin Exp Immunol       Date:  2012-11       Impact factor: 4.330

4.  Chronic immune activation in common variable immunodeficiency (CVID) is associated with elevated serum levels of soluble CD14 and CD25 but not endotoxaemia.

Authors:  J Litzman; J Nechvatalova; J Xu; O Ticha; M Vlkova; Z Hel
Journal:  Clin Exp Immunol       Date:  2012-12       Impact factor: 4.330

5.  Altered serum cytokine signature in common variable immunodeficiency.

Authors:  Zdenek Hel; Richard P H Huijbregts; Jun Xu; Jana Nechvatalova; Marcela Vlkova; Jiri Litzman
Journal:  J Clin Immunol       Date:  2014-09-23       Impact factor: 8.317

6.  Intravenous Immunoglobulins Promote an Expansion of Monocytic Myeloid-Derived Suppressor Cells (MDSC) in CVID Patients.

Authors:  Miriam Simón-Fuentes; Silvia Sánchez-Ramón; Miguel A Vega; Angel L Corbí; Ángeles Domínguez-Soto; Lidia Fernández-Paredes; Bárbara Alonso; Kissy Guevara-Hoyer
Journal:  J Clin Immunol       Date:  2022-04-29       Impact factor: 8.542

7.  Terminally differentiated memory T cells are increased in patients with common variable immunodeficiency and selective IgA deficiency.

Authors:  Jana Nechvatalova; Tomas Pavlik; Jiri Litzman; Marcela Vlkova
Journal:  Cent Eur J Immunol       Date:  2017-10-30       Impact factor: 2.085

8.  Transitional B Cells and TLR9 Responses Are Defective in Selective IgA Deficiency.

Authors:  Andri L Lemarquis; Helga K Einarsdottir; Rakel N Kristjansdottir; Ingileif Jonsdottir; Bjorn R Ludviksson
Journal:  Front Immunol       Date:  2018-04-27       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.